• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Halogenated fatty acids

Recent Advances in the Study of 2-Fluoropentanoic Acid (CAS: 1578-56-9) and Its Applications in Chemical Biology and Pharmaceutical Research

2-Fluoropentanoic acid (CAS: 1578-56-9) is a fluorinated carboxylic acid that has garnered significant attention in recent years due to its unique chemical properties and potential applications in drug discovery, metabolic studies, and chemical biology. This research briefing synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and emerging roles in pharmaceutical development.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 2-fluoropentanoic acid serves as a versatile building block for the synthesis of fluorinated analogs of bioactive molecules. The presence of the fluorine atom at the α-position significantly alters the compound's metabolic stability and lipophilicity, making it an attractive candidate for prodrug design. Researchers successfully incorporated this moiety into several lead compounds, showing improved pharmacokinetic profiles compared to their non-fluorinated counterparts.

In the field of enzyme inhibition, recent work has explored 2-fluoropentanoic acid as a potential inhibitor of fatty acid metabolism enzymes. A 2024 paper in ACS Chemical Biology reported that this compound exhibits selective inhibition against enoyl-CoA hydratase, an enzyme crucial in fatty acid β-oxidation. The study utilized X-ray crystallography to reveal the precise binding mode of 2-fluoropentanoic acid within the enzyme's active site, providing valuable structural insights for future inhibitor design.

The compound's role in metabolic pathway analysis has also seen advancements. A multinational research team recently developed a novel ¹⁹F NMR-based method using 2-fluoropentanoic acid as a metabolic tracer. This approach, detailed in a 2024 Nature Chemical Biology publication, enables real-time monitoring of fatty acid metabolism in living cells with unprecedented sensitivity. The technique has particular promise for studying metabolic disorders and cancer cell metabolism.

From a synthetic chemistry perspective, significant progress has been made in the asymmetric synthesis of 2-fluoropentanoic acid. A 2023 Organic Letters report described an efficient enzymatic resolution method that produces enantiomerically pure (R)- and (S)-forms of the compound. This development is particularly important as the biological activity of fluorinated compounds often shows marked stereospecificity.

In pharmaceutical applications, 2-fluoropentanoic acid has emerged as a key intermediate in the synthesis of novel antiviral agents. Recent patent filings (WO2023124567) disclose its use in creating fluorinated nucleoside analogs with enhanced activity against RNA viruses. The fluorination at the pentanoic acid moiety appears to confer improved cellular uptake and metabolic stability to these antiviral compounds.

Looking forward, the unique properties of 2-fluoropentanoic acid (CAS: 1578-56-9) position it as a compound of continuing interest across multiple research domains. Current studies are exploring its potential in targeted drug delivery systems, where its metabolic properties may enable tissue-specific accumulation of therapeutic agents. Additionally, its applications in PET radiopharmaceutical development are being actively investigated, leveraging the ¹⁸F isotope for diagnostic imaging purposes.

• 89270-22-4(2-FLUOROPALMITIC ACID)
• 16518-94-8(2-Fluorohexadecanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)